{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Mafosfamide",
  "nciThesaurus": {
    "casRegistry": "88859-04-5",
    "chebiId": "",
    "chemicalFormula": "C9H19Cl2N2O5PS2",
    "definition": "A synthetic oxazaphosphorine derivative with antineoplastic properties.  Mafosfamide alkylates DNA, forming DNA cross-links and inhibiting DNA synthesis.  Although closely related to cyclophosphamide, mafosfamide, unlike cyclophosphamide, does not require hepatic activation to generate its active metabolite 4-hydroxy-cyclophosphamide; accordingly, mafosfamide is potentially useful in the intrathecal treatment of neoplastic meningitis.",
    "fdaUniiCode": "5970HH9923",
    "identifier": "C1150",
    "preferredName": "Mafosfamide",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C697"
    ],
    "synonyms": [
      "MAFOSFAMIDE",
      "Mafosfamide",
      "mafosfamide"
    ]
  }
}